HomeDAWN • NASDAQ
add
Day One Biopharmaceuticals Inc
Previous close
$16.03
Day range
$15.76 - $16.38
Year range
$9.67 - $18.07
Market cap
1.41B USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 61.77M | 34.70% |
Net income | -62.41M | -47.22% |
Net profit margin | — | — |
Earnings per share | -0.72 | -22.03% |
EBITDA | -61.74M | -34.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 317.94M | -0.07% |
Total assets | 326.64M | 0.95% |
Total liabilities | 29.84M | 28.91% |
Total equity | 296.81M | — |
Shares outstanding | 87.39M | — |
Price to book | 4.71 | — |
Return on assets | -43.95% | — |
Return on capital | -47.95% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -62.41M | -47.22% |
Cash from operations | -49.73M | -91.38% |
Cash from investing | 89.29M | 897.71% |
Cash from financing | 48.00K | -95.95% |
Net change in cash | 39.61M | 210.04% |
Free cash flow | -24.57M | -113.04% |
About
Founded
2018
Headquarters
Website
Employees
174